# Sherry Shi

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/sherry-shi/

## Facts

| Field | Value |
| --- | --- |
| Citations | 515 |
| Field | Inflammatory Bowel Disease |
| h-index | 13 |
| i10-index | 17 |
| Last Known Institution | Group for Research in Decision Analysis |
| OpenAlex ID | https://openalex.org/A5110631361 |
| Works | 72 |

## Researcher papers

- [Patients Hospitalized for De Novo Versus Worsening Chronic Heart Failure in the United States](https://scholariq.org/papers/patients-hospitalized-for-de-novo-versus-worsening-chronic-heart-failure-in-the/)
- [Overall survival in patients with glioblastoma before and after bevacizumab approval](https://scholariq.org/papers/overall-survival-in-patients-with-glioblastoma-before-and-after-bevacizumab/)
- [Treatment patterns, healthcare resource utilization, and costs in patients with acute myeloid leukemia in commercially insured and Medicare populations](https://scholariq.org/papers/treatment-patterns-healthcare-resource-utilization-and-costs-in-patients-with/)
- [Economic burden of relapse/recurrence in patients with major depressive disorder](https://scholariq.org/papers/economic-burden-of-relapse-recurrence-in-patients-with-major-depressive-disorder/)
- [Hospitalizations and healthcare costs associated with rifaximin versus lactulose treatment among commercially insured patients with hepatic encephalopathy in the United States](https://scholariq.org/papers/hospitalizations-and-healthcare-costs-associated-with-rifaximin-versus-lactulose/)
- [Comparison of Real-World Treatment Outcomes With Vedolizumab Versus Infliximab in Biologic-Naive Patients With Inflammatory Bowel Disease](https://scholariq.org/papers/comparison-of-real-world-treatment-outcomes-with-vedolizumab-versus-infliximab/)
- [Nusinersen for Spinal Muscular Atrophy in the United States: Findings From a Retrospective Claims Database Analysis](https://scholariq.org/papers/nusinersen-for-spinal-muscular-atrophy-in-the-united-states-findings-from-a/)
- [Monitoring Community Pharmacist's Quality of Care: A feasibility study of using pharmacy claims data to assess performance](https://scholariq.org/papers/monitoring-community-pharmacist-s-quality-of-care-a-feasibility-study-of-using/)
- [Comparative Effectiveness of Non-cisplatin First-line Therapies for Metastatic Urothelial Carcinoma: Phase 2 IMvigor210 Study Versus US Patients Treated in the Veterans Health Administration](https://scholariq.org/papers/comparative-effectiveness-of-non-cisplatin-first-line-therapies-for-metastatic/)
- [Factors associated with more frequent diagnostic tests and procedures in patients with irritable bowel syndrome](https://scholariq.org/papers/factors-associated-with-more-frequent-diagnostic-tests-and-procedures-in/)
- [Regional variations in prevalence and severity of autosomal dominant polycystic kidney disease in the United States](https://scholariq.org/papers/regional-variations-in-prevalence-and-severity-of-autosomal-dominant-polycystic/)
- [Epidemiology and burden of focal segmental glomerulosclerosis among United States Veterans: An analysis of Veteran’s Affairs data](https://scholariq.org/papers/epidemiology-and-burden-of-focal-segmental-glomerulosclerosis-among-united/)

## Researcher topics

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)
- [Economic and Financial Impacts of Cancer](https://scholariq.org/topics/economic-and-financial-impacts-of-cancer/)
- [Microscopic Colitis](https://scholariq.org/topics/microscopic-colitis/)
- [Musculoskeletal synovial abnormalities and treatments](https://scholariq.org/topics/musculoskeletal-synovial-abnormalities-and-treatments/)

## Researcher university

- [Group for Research in Decision Analysis](https://scholariq.org/institutions/group-for-research-in-decision-analysis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.